SCHEMBL5039574

SCHEMBL5039574

COc1ccc(-c2nc(-c3cc(OC(=O)NCC(C)C)c(C)n3Cc3ccco3)cs2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.42
MEN1 O00255 5/20 0.41
KMT2A Q03164 5/20 0.41
MAPT P10636 9/20 0.41
LMNA P02545 6/20 0.41
SMN1; SMN2 Q16637 5/20 0.41
RAB9A P51151 5/20 0.41
NPC1 O15118 4/20 0.41
MAPK1 P28482 3/20 0.41
TP53 P04637 3/20 0.41
HSD17B10 Q99714 2/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KDM4E B2RXH2 6/20 0.41
POLB P06746 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
TSHR P16473 4/20 0.40
NPSR1 Q6W5P4 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5046060 0.90 KLKB1 (0.43) ALDH1A1MAPTLMNASMN1; SMN2RAB9A
SCHEMBL5043820 0.88 KLKB1 (0.48) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL5048642 0.81 CDC25A (0.44) ALDH1A1MAPTLMNASMN1; SMN2RAB9A
SCHEMBL5039868 0.81 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL5047785 0.80 SMN1; SMN2 (0.45) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL5039689 0.79 MAPT (0.43) ALDH1A1KMT2AMAPTSMN1; SMN2RAB9A
SCHEMBL5046920 0.79 KLKB1 (0.46) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL5048727 0.79 ALDH1A1 (0.47) ALDH1A1MEN1KMT2AMAPTLMNA
SCHEMBL5049186 0.78 NPC1 (0.41) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL5048718 0.77 EIF4E (0.41) ALDH1A1KMT2AMAPTSMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-B1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP claimed